In the last trading session, 3.86 million shares of the Tenaya Therapeutics Inc (NASDAQ:TNYA) were traded, and its beta was 2.83. Most recently the company’s share price was $1.45, and it changed around -$0.05 or -3.33% from the last close, which brings the market valuation of the company to $107.02M. TNYA currently trades at a discount to its 52-week high of $7.01, offering almost -383.45% off that amount. The share price’s 52-week low was $0.99, which indicates that the current value has risen by an impressive 31.72% since then. We note from Tenaya Therapeutics Inc’s average daily trading volume that its 10-day average is 9.44 million shares, with the 3-month average coming to 4.58 million.
Tenaya Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 9 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 0 recommended TNYA as a Hold, whereas 6 deemed it a Buy, and 0 rated it as Underweight. Tenaya Therapeutics Inc is expected to report earnings per share of -0.31 for the current quarter.
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Instantly TNYA has showed a red trend with a performance of -3.33% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 1.8800 on recent trading dayincreased the stock’s daily price by 22.87%. The company’s shares are currently down -55.25% year-to-date, but still down -13.17% over the last five days. On the other hand, Tenaya Therapeutics Inc (NASDAQ:TNYA) is -55.93% down in the 30-day period. We can see from the shorts that 16.69 million shares have been sold at a short interest cover period of 3.42 day(s).
Tenaya Therapeutics Inc (TNYA) estimates and forecasts
Tenaya Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -56.97 percent over the past six months and at a 19.64% annual growth rate that is well above the industry average of 16.70%.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -27.43%.
TNYA Dividends
Tenaya Therapeutics Inc’s next quarterly earnings report is expected to be released in January.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.17% of Tenaya Therapeutics Inc shares, and 73.76% of them are in the hands of institutional investors. The stock currently has a share float of 74.64%. Tenaya Therapeutics Inc stock is held by 132.0 institutions, with COLUMN GROUP LLC being the largest institutional investor. By 2024-06-30, it held 11.6078% of the shares, which is about 9.4 million shares worth $29.14 million.
RA CAPITAL MANAGEMENT, L.P., with 9.4124% or 7.62 million shares worth $23.63 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 2.1 shares worth $3.04 million, making up 2.65% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 2.06 shares worth around $2.99 million, which represents about 2.61% of the total shares outstanding.
